Uric acid ka desi ilaj

 

Uric acid is a common constituent of several organs and tissues in the body. Its main function is to regulate the production of bile acids by the liver. It is produced in excess due to high levels of uric acid in the blood and is excreted in the urine as crystals. These crystals are broken down by kidney, gallbladder, liver and pancreas enzymes.

The ability of theophylline to inhibit crystallization of urate fragments during ESWL was evaluated by using a novel flow cytometry model. This model produces multiple flow cytometric curves at a time, which is extremely difficult to do for other chemicals and biologicals. After evaluating the effect of theophylline on the production of urinary crystals, it was determined that this compound was very effective in the treatment of severe and recurrent urinary tract infections and had no effect on healthy volunteers.

It has been shown that theophylline inhibits the growth of crystals in vitro at doses that do not disturb normal blood level, thus making it a good anticholinergic. Its action in the urine is similar to that of some other anticholinergic drugs such as alprozepam.

It is not clear whether theophylline will have any effect in the (Uric acid ka desi ilaj) treatment of chronic kidney disease. However, recent data have suggested that theophylline may prevent kidney stone formation by inhibiting uric acid production by reducing the concentration of oxalate in the urine. This could be an important contribution to the treatment of renal stones in patients with renal disease.

Theophylline is also used in the treatment of hyperuricemia. Theophylline can be used alone or in combination with a sulfate-reducing diuretic to improve fluid balance. However, there is no evidence that theophylline is useful in the treatment of hyperuricemia in adults or in the treatment of other metabolic diseases such as diabetes.

In addition to treating high uric acid levels in the blood, theophylline has also been shown to reduce the risk of gallstones by reducing serum concentrations of bile acids. It also appears to prevent the formation of gallbladder stones. gallstones by reducing bile secretion by reducing the activity of acid phosphatase.

Theophylline is currently being used in combination with sulfate-reducing diuretics in the treatment of hyperuricemia and in certain other conditions. Further studies are needed to evaluate the effects of theophylline on other conditions.

Theophylline may also have some benefit in the treatment of patients with chronic kidney disease, but further research is required to confirm this benefit and to determine if it has an effect on patients who do not have chronic kidney disease. In patients with mild to moderate renal disease, theophylline has been shown to be effective in decreasing serum urate and in decreasing serum calcium concentrations.

Theophylline has been shown to have some beneficial effects in the (Uric acid ka desi ilaj) treatment of patients with liver cirrhosis. Theophylline has also been shown to be effective in the treatment of the symptoms associated with irritable bowel syndrome, which is often associated with liver disease and cirrhosis.

Theophylline is available only by prescription in the United States. Because the drug is a controlled substance, it is not available over the counter.

There are several side effects associated with the administration of theophylline, including nausea and vomiting. Because of these side effects, patients should not take theophylline for a period of time after an intestinal obstruction. If theophylline is taken in conjunction with other medications, caution should be taken to avoid gastrointestinal complications.

There are several studies ongoing to determine the effectiveness of theophylline in the treatment of patients with kidney disease. If more definitive information is gained in the future, more studies are possible to determine whether theophylline may be useful in the treatment of kidney disease.